Genpact Limited G is a well-performing stock, with a significant rise in price over the past year and strong fundamentals. Therefore, if you haven’t taken advantage of the price appreciation yet, it’s time you add the stock to your portfolio, as we believe that it has the potential to carry the momentum in the near term.
Share Price Appreciation: A glimpse at the company’s price trend reveals that the stock has had an impressive run in the past year. G has returned 38%, which compared favorably with the 32% rally of the industry and the Zacks S&P 500 composite’s 31.7% rise.
Genpact Limited price | Genpact Limited Quote
Solid Rank & VGM Score: Genpact currently carries a Zacks Rank #2 (Buy) and has a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
Northward Estimate Revisions: Six estimates for 2024 moved north over the past 30 days versus no southward revisions, reflecting analysts’ confidence in the company. Over the same period, the Zacks Consensus Estimate for 2024 increased 2.2%.
Positive Earnings Surprise History: Genpact has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering a positive average earnings surprise of 7.8%.
Strong Growth Prospects: The Zacks Consensus Estimate for the company’s 2024 earnings of $3.22 indicates year-over-year growth of 8.1%. Moreover, earnings are expected to register 6.9% growth in 2025. The stock has a long-term expected earnings per share growth rate of 9.8%.
Growth Drivers: Genpact’s focus on integrating processes, analytics and digital technologies, along with its deep domain expertise, helps it win customers regularly. We expect the expanding customer base, stringent cost control, strategic acquisitions and aggressive share repurchase to drive overall results in the long haul.
Artificial Intelligence presents significant growth opportunities for Genpact. The company’s Digital Smart Enterprise Processes (Digital SEPs) is a patented approach to enhance the performance of clients’ business processes. Digital SEPs decrease inefficiency and improve process quality using AI, advanced domain-specific digital technologies, Lean Six Sigma methodologies and experience-centric principles.
Genpact has a consistent record of returning value to shareholders through share repurchases and dividend payments. During 2023, 2022 and 2021, the company repurchased shares worth $225.4 million, $214.1 million and $298.2 million, respectively. The company paid $100 million, $91.8 million and $80.5 million in dividends to its shareholders during 2023, 2022 and 2021, respectively. Such moves indicate the company’s commitment to create value for shareholders and underline its confidence in its business.
Genpact's current ratio at the end of third-quarter 2024 was pegged at 1.85, higher than the industry average of 1.08. A current ratio of more than 1often indicates that the company will be easily paying off its short-term obligations.
Some other top-ranked stocks in the broader Zacks Business Services sector are Parsons PSN and Qifu Technology, Inc. QFIN.
Parsons sports a Zacks Rank of 1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
PSN has a long-term earnings growth expectation of 18.6%. It delivered a trailing four-quarter earnings surprise of 17.5%, on average.
Qifu Technology sports a Zacks Rank of 1 at present. It has a long-term earnings growth expectation of 20.9%.
QFIN delivered a trailing four-quarter earnings surprise of 12.4%, on average.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Genpact Limited (G) : Free Stock Analysis Report
Qifu Technology, Inc. (QFIN) : Free Stock Analysis Report
Parsons Corporation (PSN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。